/Investor DB

468 Capital — 2024 Investments

9 investments dated 2024 · listed companies and verified rows first · show all

Marley Spoonmarleyspoon.comin𝕏Apr 2024

Marley Spoon is a meal kit delivery service that provides fresh food and recipes to consumers.

Direct to ConsumerE-commerceFoodTechBerlin, DE

Fabian Siegel(Founder)inJennifer Bernstein(Chief Financial Officer)inDaniel Raab(Chief Operations Officer)inKatalin Fritz(Chief Customer Officer)inNasreen Abdujaleel(Chief Technology Officer)Federico Rossi(Chief Marketing Officer)in

Board seatAlexander Kudlich· per SEC Form D

Co-investorsBerliner Volksbank VenturesLifeX VenturesPoint NineRedstoneRunway Growth CapitalTane Fund+7 more

Actoheyacto.cominMar 2024

Acto is an AI sales tool for wholesale distributors that analyzes ERP and CRM data to give field sales teams weekly recommendations on which customers need attention, churn risks, and cross-sell/upsell opportunities.

AI & Machine LearningSaaSSales Tech

Co-investorsAdesso venturesCusp Capital

Codespherecodesphere.comin𝕏May 2024

Codesphere provides a cloud platform and consulting focused on helping enterprise IT and software teams deliver projects on schedule and within budget.

Cloud ComputingDeveloper ToolsEnterprise SoftwareKarlsruhe, DE

Elias Schneider(Founder)inJonas Zipprick(Founder)Elias Groll(Founder)Roman Frolov(Founder)

BoardCarl Fritjofsson(Director)in

Co-investors42CAPBegin CapitalCompanion M Gmb HFirestreak VenturesHOF CapitalLEA Partners+1 more

einwerteinwert.cominJan 2024

Einwert provides a platform for real estate professionals and investors to obtain certified property valuations and access centralized market data, proprietary property data, and automated workflows.

FintechPropTechSaaSMunich, DE

Dr. Christina Mauer(Founder)inChristina Mauer(Founder)Maximilian Schlachter(Founder)

Co-investorsAuxxoInfinitasInfinitas CapitalVentech

Exin Therapeuticsexintherapeutics.comin𝕏Nov 2024

Exin Therapeutics develops an AI-guided drug discovery platform that uses experimental mouse studies to identify neurological therapies, starting with epilepsies linked to autism and Parkinson's disease.

BiotechHealthtechSan Francisco, US

Gabriel Ocana Santero(Founder)inMarko Tvrdic(Founder)inIvan Alex Priela Lazarte(Executive Officer, Director)inIvan Lazarte(Founder)

Co-investorsAlumni VenturesY CombinatorFounder CapitalOurCrowdTekedia CapitalTheory Ventures

Ideogramideogram.aiinFeb 2024

Toronto-based generative AI company building text-to-image models known for accurate in-image text rendering.

Toronto, CA

William Chan(Founder)inMohammad Norouzi(Founder)inChitwan Saharia(Founder)Jonathan Ho(Founder)

Co-investorsAIX VenturesAndreessen HorowitzIndex VenturesPear VCRedpoint VenturesTwo Small Fish Ventures+11 more

KARRIkarri.ioinMay 2024

Karri builds technology that helps families maintain confident connections by providing children with age-appropriate freedom while giving parents visibility and reassurance.

ConsumerDigital HealthHardwareIoT

Co-investorsAENUEmerge Education

Starcloudstarcloud.comin𝕏Dec 2024

Starcloud is a deep-tech company building large-scale data center infrastructure designed to operate in space.

Advanced ManufacturingAI & Machine LearningClimate TechCloud ComputingData & InfrastructureDeep TechSemiconductorsSpace TechRedmond, US

Philip Johnston(Founder)inEzra Feilden(Founder)inAdi Oltean(Founder)inPaul Adrian Oltean(Executive Officer, Director)Philip Johnston Ezra Feilden(Founder)

BoardMorgan Beller(Director)in

Co-investorsAb Capital Holding BVAmbush CapitalCisco InvestmentsDnx VenturesDragon CapitalFUSE+57 more

Yoneda Labsyonedalabs.comin𝕏Apr 2024 · $4M

Yoneda Labs applies AI/ML and high-throughput experimentation (HTE) to chemical reaction optimization, including cross-coupling reactions, for the life sciences and pharmaceutical research market.

AI & Machine LearningBiotechDeep TechEnterprise SoftwareSan Francisco, US

Michał Mgeładze-Arciuch(Founder)inJan Oboril(Founder)inDaniel Vlasits(Founder)in

Co-investors500 Emerging EuropeAlumni VenturesBasecamp FundDG Daiwa VenturesFundamental VenturesJude Gomila+12 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.